Top Markets
Coin of the day
Aeglea BioTherapeutics, Inc. Aeglea BioTherapeutics, Inc.

Aeglea BioTherapeutics, Inc.

AGLE
Rang în acțiuni #23495
Aeglea BioTherapeutics, Inc. is a clinical-stage biotechnology firm dedicated... Aeglea BioTherapeutics, Inc. is a clinical-stage biotechnology firm dedicated to creating human enzyme therapies for rare metabolic diseases. Their leading candidate, pegzilarginase, a recombinant human Arginase 1, is currently in the pivotal Phase III PEACE trial to assess its safety and effectiveness for treating Arginase 1 deficiency. Furthermore, the company is developing AGLE-177, a polyethylene glycol modified enzyme, which is progressing through Phase I/II clinical trials for homocystinuria. Their early-stage pipeline includes AGLE-325 for cystinuria, along with other ongoing research initiatives. Founded in 2013, the company was initially known as Aeglea BioTherapeutics Holdings, LLC, changing its name to Aeglea BioTherapeutics, Inc. in March 2015. It is based in Austin, Texas.
Preț acțiune
$19.30
Ultima sincronizare: 2023-12-26
Capitalizare de piață
$72.77M
Schimbare (1 zi)
6.22%
Schimbare (1 an)
0.00%
Țară
US
Tranzacționează Aeglea BioTherapeutics, Inc. (AGLE)

Categorie

Istoricul spliturilor pentru Aeglea BioTherapeutics, Inc. (AGLE)
Acțiunea Aeglea BioTherapeutics, Inc. (simbol: AGLE) a trecut printr-un total de 0 splituri.
Cel mai recent split a avut loc pe Aug 22, 2026.
O acțiune AGLE cumpărată înainte de Aug 22, 2026 este echivalentă astăzi cu 0 acțiuni AGLE.
Listă splituri acțiuni
An Split Multiplu Multiplu cumulativ
Nu sunt suficiente date pentru perioada selectată.
Splituri pentru companii similare sau competitori
Companie Număr total de splituri Multiplu cumulativ Țara
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH